Retroauricular subperiosteal <i>vs</i> systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness

In treating patients with diabetes and SD, retroauricular subperiosteal injection of methylprednisolone offers superior therapeutic efficacy and lower incidence of adverse reactions compared with systemic intravenous GC administration, with minimal impact on blood glucose.